KalVista Pharmaceuticals, Inc. Quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD from Q4 2013 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
KalVista Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Operating Loss Carryforwards history and growth rate from Q4 2013 to Q1 2024.
  • KalVista Pharmaceuticals, Inc. Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending April 30, 2024 was $50.2M, a 40.2% increase year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $50.2M +$14.4M +40.2% Apr 30, 2024 10-K 2024-07-11
Q1 2023 $35.8M +$12.6M +54.1% Apr 30, 2023 10-K 2024-07-11
Q1 2022 $23.2M +$8.81M +61.1% Apr 30, 2022 10-K 2023-07-10
Q1 2021 $14.4M +$7.04M +95.6% Apr 30, 2021 10-K 2022-07-07
Q1 2020 $7.37M -$57K -0.77% Apr 30, 2020 10-K 2021-07-13
Q1 2019 $7.42M +$828K +12.6% Apr 30, 2019 10-K 2020-07-01
Q1 2018 $6.6M +$994K +17.7% Apr 30, 2018 10-K 2019-07-16
Q1 2017 $5.6M +$2.85M +103% Apr 30, 2017 10-K 2018-07-30
Q1 2016 $2.76M Apr 30, 2016 10-K 2017-07-27
Q4 2015 $26.9M +$9.48M +54.3% Dec 31, 2015 10-K 2016-03-30
Q4 2014 $17.4M +$4.23M +32% Dec 31, 2014 10-K 2016-03-30
Q4 2013 $13.2M Dec 31, 2013 10-K 2016-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.